Beijing-based biotech firms Cell Store, a biological sample cryopreservation technology platform, and Cygenta, a Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapy (CGT), have entered into a long-term strategic alliance. Financial terms of the partnership were not disclosed.
Partnership Details
The alliance aims to leverage Cell Store’s expertise in cryopreservation and Cygenta’s capabilities in CGT development and manufacturing. The collaboration is expected to accelerate innovation and production in the rapidly evolving CGT sector, though specific project details remain under wraps.
Company Backgrounds
Cell Store provides advanced solutions for biological sample storage, while Cygenta focuses on end-to-end CDMO services for CGT therapies. The partnership underscores both firms’ commitment to advancing therapies targeting genetic and cellular diseases.
Industry Impact
The alliance comes amid growing demand for CGT solutions globally. Analysts say the partnership could position the companies as key players in China’s burgeoning CGT market, though competitive pressures and regulatory hurdles remain challenges for the sector.-Fineline Info & Tech
Leave a Reply